Age, Biography and Wiki
Joseph Biederman was born on 29 September, 1947 in Massachusetts. Discover Joseph Biederman's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 76 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
75 years old |
| Zodiac Sign |
Libra |
| Born |
29 September, 1947 |
| Birthday |
29 September |
| Birthplace |
Prague, Czechoslovakia |
| Date of death |
January 5, 2023 |
| Died Place |
Boston, Massachusetts, USA |
| Nationality |
United States |
We recommend you to check the complete list of Famous People born on 29 September.
He is a member of famous with the age 75 years old group.
Joseph Biederman Height, Weight & Measurements
At 75 years old, Joseph Biederman height not available right now. We will update Joseph Biederman's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Joseph Biederman Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Joseph Biederman worth at the age of 75 years old? Joseph Biederman’s income source is mostly from being a successful . He is from United States. We have estimated
Joseph Biederman's net worth
, money, salary, income, and assets.
| Net Worth in 2023 |
$1 Million - $5 Million |
| Salary in 2023 |
Under Review |
| Net Worth in 2022 |
Pending |
| Salary in 2022 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Joseph Biederman Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
According to ProPublica's drug company money database, Biederman received over $3,000 from pharmaceutical company Shire's North American division in 2018, mainly for consulting.
These allegations prompted an investigation by the Massachusetts General Hospital and Harvard Medical School. Biederman has said that he was not influenced by the money and that some of his work supported drugs other than Risperdal. In 2011, Massachusetts General Hospital and Harvard Medical School disciplined Biederman for small violations of conflict of interest policies but did not identify their specific breaches of policy. He retains his academic standing at Harvard and his clinical position at Massachusetts General Hospital.
In 2008, Senator Chuck Grassley, chairman of the Senate Finance Committee, undertook a Congressional investigation that alleged that Joseph Biederman, along with two other psychiatrists, had violated federal regulations in addition to Harvard Medical School's and Massachusetts General Hospital's research rules by receiving large sums of money from the pharmaceutical companies. He received research funding from 15 drug companies and served as a paid speaker or adviser to seven, including Eli Lilly & Co. and Janssen Pharmaceuticals. Biederman earned consulting fees of at least $1.6 million over eight years from pharmaceutical companies while failing to accurately report the income to his other employers. In 2001, Biederman failed to report any income from Johnson & Johnson; when asked about this later, he said he received $3,500. In contrast, Johnson & Johnson reported that they paid him over $58,000 in 2001. Johnson & Johnson also gave more than $700,000 to a research center that was headed by Biederman from 2002 to 2005, which was involved in research on Risperdal, the company's antipsychotic drug.
Joseph Biederman (29 September 1947 - 5 January 2023) was Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD at the Massachusetts General Hospital, professor of psychiatry at Harvard Medical School. Biederman was Board Certified in General and Child Psychiatry.
